| Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia SJ Conley, E Gheordunescu, P Kakarala, B Newman, H Korkaya, ... Proceedings of the National Academy of Sciences 109 (8), 2784-2789, 2012 | 748 | 2012 |
| Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells Y Li, T Zhang, H Korkaya, S Liu, HF Lee, B Newman, Y Yu, SG Clouthier, ... Clinical Cancer Research 16 (9), 2580-2590, 2010 | 668 | 2010 |
| Withaferin A targets heat shock protein 90 in pancreatic cancer cells Y Yu, A Hamza, T Zhang, M Gu, P Zou, B Newman, Y Li, AAL Gunatilaka, ... Biochemical pharmacology 79 (4), 542-551, 2010 | 351 | 2010 |
| Heat effects on drug delivery across human skin J Hao, P Ghosh, SK Li, B Newman, GB Kasting, SG Raney Expert opinion on drug delivery 13 (5), 755-768, 2016 | 101 | 2016 |
| Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options JP Burnett, H Korkaya, MD Ouzounova, H Jiang, SJ Conley, BW Newman, ... Scientific reports 5 (1), 15821, 2015 | 79 | 2015 |
| HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells B Newman, Y Liu, HF Lee, D Sun, Y Wang Cancer research 72 (17), 4551-4561, 2012 | 77 | 2012 |
| In vitro and ex vivo correlation of drug release from ophthalmic ointments Q Bao, B Newman, Y Wang, S Choi, DJ Burgess Journal of Controlled Release 276, 93-101, 2018 | 62 | 2018 |
| In vitro release testing method development for ophthalmic ointments Q Bao, J Shen, R Jog, C Zhang, B Newman, Y Wang, S Choi, DJ Burgess International journal of pharmaceutics 526 (1-2), 145-156, 2017 | 38 | 2017 |
| Physicochemical attributes and dissolution testing of ophthalmic ointments Q Bao, R Jog, J Shen, B Newman, Y Wang, S Choi, DJ Burgess International journal of pharmaceutics 523 (1), 310-319, 2017 | 37 | 2017 |
| Targeting cancer stem cells with natural products J Burnett, B Newman, D Sun Current Drug Targets 13 (8), 1054-1064, 2012 | 33 | 2012 |
| Navigating sticky areas in transdermal product development C Strasinger, SG Raney, DC Tran, P Ghosh, B Newman, ED Bashaw, ... Journal of Controlled Release 233, 1-9, 2016 | 31 | 2016 |
| On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with … SH Shin, P Ghosh, B Newman, DC Hammell, SG Raney, HE Hassan, ... Pharmaceutical Research 34, 1817-1830, 2017 | 30 | 2017 |
| Addressing the regulatory and scientific challenges with generic orally inhaled drug products B Newman, K Witzmann Pharmaceutical medicine 34, 93-102, 2020 | 27 | 2020 |
| Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro Q Zhang, M Murawsky, T LaCount, J Hao, GB Kasting, B Newman, ... Pharmaceutical research 34, 1491-1504, 2017 | 26 | 2017 |
| Influence of manufacturing process variables on the properties of ophthalmic ointments of tobramycin S Patere, B Newman, Y Wang, S Choi, S Vora, AWK Ma, M Jay, X Lu Pharmaceutical Research 35, 1-16, 2018 | 23 | 2018 |
| MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells T Zhang, Y Li, Z Zhu, M Gu, B Newman, D Sun Molecular pharmaceutics 7 (5), 1576-1584, 2010 | 23 | 2010 |
| Scientific and regulatory activities initiated by the US food and drug administration to foster approvals of generic dry powder inhalers: bioequivalence perspective B Newman, A Babiskin, E Bielski, S Boc, S Dhapare, L Fang, K Feibus, ... Advanced Drug Delivery Reviews 190, 114526, 2022 | 16 | 2022 |
| Mechanistic modeling of generic orally inhaled drug products: A workshop summary report RL Walenga, C Butler, BA Craven, PW Longest, R Mohamed, B Newman, ... CPT: Pharmacometrics & Systems Pharmacology 12 (5), 560-574, 2023 | 9 | 2023 |
| Advancements in the design and development of dry powder inhalers and potential implications for generic development AR Mohan, Q Wang, S Dhapare, E Bielski, A Kaviratna, L Han, S Boc, ... Pharmaceutics 14 (11), 2495, 2022 | 9 | 2022 |
| Scientific and regulatory activities initiated by the US Food and Drug Administration to foster approvals of generic dry powder inhalers: quality perspective N El-Gendy, CM Bertha, M Abd El-Shafy, DK Gaglani, A Babiskin, ... Advanced Drug Delivery Reviews 189, 114519, 2022 | 8 | 2022 |
